---
figid: PMC6198234__CAM4-7-5083-g005
figlink: /pmc/articles/PMC6198234/figure/cam41748-fig-0005/
number: F5
caption: Proposed mechanisms by which PKM2‐mTORC1 regulatory pathways contribute to
  resistance in RCC cells. Overexpression of PKM2 leads to accumulation of anabolic
  intermediates and activation of mTOR signaling, which promotes utilization of anabolic
  intermediates and inhibits autophagy. Meanwhile, mTORC1 activates PKM2 to form a
  positive loop to enhance the anabolic processes. Signals that activate either PKM2
  or mTORC1 can result in anabolic functions. In this pathway, mRCC cells can be sensitized
  to everolimus by combination treatment with MC‐4 via inhibition of PI3K/PKM2/mTOR
  signaling pathways
pmcid: PMC6198234
papertitle: Novel therapeutic roles of MC‐4 in combination with everolimus against
  advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme
  M2 and mechanistic target of rapamycin complex 1 pathways.
reftext: Ji Yeon Son, et al. Cancer Med. 2018 Oct;7(10):5083-5095.
pmc_ranked_result_index: '19912'
pathway_score: 0.9321052
filename: CAM4-7-5083-g005.jpg
figtitle: Proposed mechanisms by which PKM2‐mTORC1 regulatory pathways contribute
  to resistance in RCC cells
year: '2018'
organisms:
- Homo sapiens
ndex: eb87e1f3-df06-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6198234__CAM4-7-5083-g005.html
  '@type': Dataset
  description: Proposed mechanisms by which PKM2‐mTORC1 regulatory pathways contribute
    to resistance in RCC cells. Overexpression of PKM2 leads to accumulation of anabolic
    intermediates and activation of mTOR signaling, which promotes utilization of
    anabolic intermediates and inhibits autophagy. Meanwhile, mTORC1 activates PKM2
    to form a positive loop to enhance the anabolic processes. Signals that activate
    either PKM2 or mTORC1 can result in anabolic functions. In this pathway, mRCC
    cells can be sensitized to everolimus by combination treatment with MC‐4 via inhibition
    of PI3K/PKM2/mTOR signaling pathways
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R3
  - PIK3R4
  - PIK3CA
  - RICTOR
  - MAPKAP1
  - AKT2
  - MTOR
  - PIK3CB
  - PIK3CD
  - PDK1
  - PIK3R6
  - AKT1
  - PKM
  - PIK3CG
  - AKT3
  - MLST8
  - RORC
  - RPTOR
  - PIK3R5
  - XRCC1
  - PTEN
  - Temsirolimus
  - Everolimus
  - RCC
  - tumor
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKM2
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Rictor
  symbol: RICTOR
  source: hgnc_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: TOR
  symbol: TOR
  source: hgnc_alias_symbol
  hgnc_symbol: RORC
  entrez: '6097'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: RCC
  symbol: RCC
  source: hgnc_prev_symbol
  hgnc_symbol: XRCC1
  entrez: '7515'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Everolimus
  source: MESH
  identifier: C107135
diseases:
- word: RCC
  source: MESH
  identifier: C538614
- word: tumor
  source: MESH
  identifier: D009369
figid_alias: PMC6198234__F5
redirect_from: /figures/PMC6198234__F5
figtype: Figure
---
